Multiple Daily Injections

OTHER2 trials

Sponsors

University of Cambridge, University of Virginia

Conditions

Diabetes MellitusEnd Stage Renal Disease (ESRD)Insulin-requiring Type 2 Diabetes MellitusType 1 Diabetes

Unknown Phase

Closed Loop From Onset in Type 1 Diabetes

Active, not recruitingNCT02871089

University of CambridgeDiabetes Mellitus, Type 1 Diabetes

Start: 2017-01-31End: 2024-07-31Target: 96Updated: 2024-05-16

Use of Closed Loop Insulin Delivery for Glucose Control in Patients With Insulin Dependent Diabetes Mellitus After Kidney Transplantation

WithdrawnNCT04189510

University of VirginiaEnd Stage Renal Disease (ESRD), Insulin-requiring Type 2 Diabetes Mellitus, Type 1 Diabetes

Start: 2021-04-01End: 2021-12-31Updated: 2021-11-10

Related Papers

The effect of closed-loop glucose control on C-peptide secretion in youth with newly diagnosed type 1 diabetes: the CLOuD RCT

Efficacy and Mechanism Evaluation2024-05-011 citations

Diabetic Ketoacidosis at Onset of Type 1 Diabetes and Glycemic Outcomes with Closed-Loop Insulin Delivery

Diabetes Technology & Therapeutics2024-03-018 citations

Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 Diabetes

New England Journal of Medicine2022-09-0799 citations

Adolescents’ Experiences of Using a Smartphone Application Hosting a Closed-loop Algorithm to Manage Type 1 Diabetes in Everyday Life: Qualitative Study

Journal of Diabetes Science and Technology2021-07-1423 citations

Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol.

Apollo (University of Cambridge)2020-03-12

Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol

BMJ Open2020-03-0120 citations